Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sarepta Therapeutics Inc (NASDAQ:SRPT)

30.01
Delayed Data
As of 3:59pm ET
 -0.84 / -2.72%
Today’s Change
14.83
Today|||52-Week Range
63.73
+9.41%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.7B

Company Description

Sarepta Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the discovery and development of unique RNA-targeted therapeutics for the treatment of rare, infectious, and other diseases. It focuses on the development of its potentially disease-modifying DMD drug candidates. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Contact Information

Sarepta Therapeutics, Inc.
215 First Street
Cambridge Massachusetts 02142
P:(857) 242-4000
Investor Relations:
(617) 274-4052

Employees

Shareholders

Individual stakeholders6.75%
Other institutional44.16%
Mutual fund holders32.98%

Top Executives

Edward M. KayePresident & Director
Sandesh MahatmeExecutive VP, Chief Financial & Business Officer
Catherine Stehman BreenChief Medical Officer
TY HowtonSecretary, Senior Vice President & General Counsel
Joan WoodVice President & Head-Human Resources